Showing 3171-3180 of 5662 results for "".
@PRACTICAL_DERM
https://practicaldermatology.com/topics/practice-management/practical_derm/21200/Your Destination for the Latest Developments in #Dermatology in Print and Online.New Products
https://practicaldermatology.com/columns/new-products/new-products/21262/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21616/New products and pharmacologic developments- Derms on Sunscreen: Do As We Say and As We Dohttps://practicaldermatology.com/news/derms-on-sunscreen-do-as-we-say-and-as-we-do/2458558/Dermatologists are all on the same page when it comes to sunscreen safety and effectiveness, according to a new survey from the National Society for Cutaneous Medicine (NSCM). Fully 99 percent dermatologists agree that regular use of sunscreens hel
- The Foundation for Research and Education in Dermatology Welcomes Matt L. Leavitt, DO to Boardhttps://practicaldermatology.com/news/the-foundation-for-research-and-education-in-dermatology-welcomes-matt-l-leavitt-do-to-board/2461281/The Foundation for Research and Education in Dermatology (FRED), has named Matt L. Leavitt, DO as new member of its board. The Foundation says this decision marks the latest step in expanding its leadership at the executive and advisory levels. Dr. Leavitt is a board-certified derm
- Dove: Women's Shower Routines May Do More Harm Than Goodhttps://practicaldermatology.com/news/dove-womens-shower-routines-may-do-more-harm-than-good/2458043/Close to 80 percent of dermatologists believe women often focus on facial skincare, but neglect body skincare, according to new research from Dove. What’s more, 69 percent of dermatologists report that many women use gentle facial c
- PsA Patients Failing Anti-TNF Drugs May Do Well on Taltzhttps://practicaldermatology.com/news/psa-patients-who-fail-anti-tnf-drugs-may-do-well-on-taltz/2458154/New data show that Taltz (ixekizumab) improved the signs and symptoms of active psoriatic arthritis (PsA) in patients who had inadequate response to one or two TNF inhibitors or were intolerant of TNF inhibitors treated. Eli Lilly has filed a supple
- Do the FDA's Proposed Regulations on Tanning Bed Use Go Far Enough?https://practicaldermatology.com/news/do-the-fdas-proposed-regulations-on-tanning-bed-use-go-far-enough/2458646/As the comment period on the US Food and Drug Administration’s proposal to restrict tanning bed use winds down, researchers are weighing in on the proposal's merits and potential shortfalls. Investigators
- Study: Newer Biologics Do Not Increase MACE/VTE Risk in PsO/PsAhttps://practicaldermatology.com/news/Study-Newer-Biologics-Do-Not-Increase-MACE-VTE-Risk-PsO-PsA/2471065/A new emulated target trial analysis found no significant risk differences in major adverse cardiovascular events (MACE) or venous thromboembolic events (VTE) in patients with psoriasis or psoriatic arthritis treated with IL-17, IL-12/23, or IL-23 inhibitors vs those treated with TNF inhibitors.<
- ‘SUNucate’ Laws Do Increase Interest in Sun Protection, Youth Sunscreen Usehttps://practicaldermatology.com/news/sunucate-laws-do-increase-interest-in-sun-protection-youth-sunscreen-use/2461998/States that enacted SUNUCATE laws permitting children to carry and apply sunscreen at school experienced an increased interest in sun protection and a higher rate of sunscreen use among adolescents, according to new research by a University of Massachusetts Amherst resource economist.